Solventum (SOLV) is updating its full year 2025 guidance to reflect underlying business performance and flexibility to navigate the dynamic macroeconomic environment as follows: Increased Organic sales growth range to +1.5% to +2.5% from prior range of +1.0% to +2.0%; Adjusted EPS in the range of $5.45 to $5.65, no change; Free cash flow in the range of $450M to $550M, no change
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum price target lowered to $80 from $84 at Piper Sandler
- Solventum Corporation: Promising Growth Amidst Execution Challenges Justifies Hold Rating
- Cautious Outlook for Solventum Corporation Amid Turnaround Strategy and Valuation Debates
- Balanced Outlook for Solventum Corporation Amid Divestiture and Cost Challenges
- Early notable gainers among liquid option names on March 20th